For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Summary
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Market Segment as follows:
By Region
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
By Type
- Platelet aggregation inhibitors (PAI)
- Low-molecular-weight Heparin (LMWH)
- Direct thrombin inhibitor (DTI)
- Direct factor Xa inhibitors (DFXa)
- Vitamin K antagonists (VKA)
- Others
By Application
- VTE
- ACS/MI
- AF
- Others
By Company
- Bayer
- Sanofi
- Boehringer Ingelheim
- Johnson & Johnson
- Genentech (Roche)
- AstraZeneca
- Bristol-Myers Squibb
- Aspen
- Lilly
- Otsuka
- Pfizer
- Daiichi Sankyo
- The Medicines Company
The main contents of the report including:
Section 1: Product definition, type and application, global and regional market overview;
Section 2: Global and regional Market competition by company;
Section 3: Global and regional sales revenue, volume and price by type;
Section 4: Global and regional sales revenue, volume and price by application;
Section 5: Regional export and import;
Section 6: Company information, business overview, sales data and product specifications;
Section 7: Industry chain and raw materials;
Section 8: SWOT and Porter's Five Forces;
Section 9: Conclusion.